These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 36698860

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Randomized, double-blind, placebo-controlled study to assess the efficacy and safety of vortioxetine in Japanese patients with major depressive disorder.
    Inoue T, Sasai K, Kitagawa T, Nishimura A, Inada I.
    Psychiatry Clin Neurosci; 2020 Feb; 74(2):140-148. PubMed ID: 31725942
    [Abstract] [Full Text] [Related]

  • 3. Safety and effectiveness of vortioxetine for major depressive disorder: Real-world evidence from a population-based study in South Korea.
    Moon SW, Kim JW, Kim DH, Lee KY, Reines EH, Lee M, Park YJ.
    Front Psychiatry; 2023 Feb; 14():1075939. PubMed ID: 36937717
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effectiveness of Vortioxetine on Emotional Blunting in Patients with Major Depressive Disorder with inadequate response to SSRI/SNRI treatment.
    Fagiolini A, Florea I, Loft H, Christensen MC.
    J Affect Disord; 2021 Mar 15; 283():472-479. PubMed ID: 33516560
    [Abstract] [Full Text] [Related]

  • 12. A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder.
    Mahableshwarkar AR, Zajecka J, Jacobson W, Chen Y, Keefe RS.
    Neuropsychopharmacology; 2015 Jul 15; 40(8):2025-37. PubMed ID: 25687662
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Safety and effectiveness of vortioxetine in patients with major depressive disorder in a real-life clinical setting in India: results from an interventional, flexible-dose study.
    Adair M, Bose R, Schmidt SN.
    Curr Med Res Opin; 2024 Sep 15; 40(9):1637-1645. PubMed ID: 39110846
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of Vortioxetine on Cognitive Impairment in Patients With Major Depressive Disorder: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Huang IC, Chang TS, Chen C, Sung JY.
    Int J Neuropsychopharmacol; 2022 Dec 12; 25(12):969-978. PubMed ID: 35981958
    [Abstract] [Full Text] [Related]

  • 18. Comparison of vortioxetine versus venlafaxine XR in adults in Asia with major depressive disorder: a randomized, double-blind study.
    Wang G, Gislum M, Filippov G, Montgomery S.
    Curr Med Res Opin; 2015 Apr 12; 31(4):785-94. PubMed ID: 25650503
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of Vortioxetine in Working Patients with Major Depressive Disorder in China: A Subgroup Analysis of the RELIEVE China Study.
    Wang G, Si T, Rieckmann A, Ma J, Christensen MC.
    Neuropsychiatr Dis Treat; 2024 Apr 12; 20():1211-1223. PubMed ID: 38863483
    [Abstract] [Full Text] [Related]

  • 20. The Effects of Vortioxetine on Cognitive Function in Patients with Major Depressive Disorder: A Meta-Analysis of Three Randomized Controlled Trials.
    McIntyre RS, Harrison J, Loft H, Jacobson W, Olsen CK.
    Int J Neuropsychopharmacol; 2016 Jun 15; 19(10):. PubMed ID: 27312740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.